toxicities < toxicity < toxicogenomics

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 120.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2005)	Radouil Tzekov [États-Unis]	Ocular Toxicity Due to Chloroquine and Hydroxychloroquine:Electrophysiological and Visual Function Correlates
000006 (1983)	Evan W. Mcchesney [États-Unis]	Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate
000010 (2006)	Vicente Giner Galva [Espagne] ; María Rosa Oltra [Espagne] ; Diego Rueda [Espagne] ; María José Esteban [Espagne] ; Josep Red N [Espagne]	Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease
000011 (2009)	Gabriele Fragasso [Italie] ; Francesca Sanvito [Italie] ; Francesca Baratto [Italie] ; Sabina Martinenghi [Italie] ; Claudio Doglioni [Italie] ; Alberto Margonato [Italie]	Cardiotoxicity after low-dose chloroquine antimalarial therapy
000014 (1988)	Harold E. Paulus [États-Unis]	Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugs
000018 (1983)	Allen H. Mackenzie [États-Unis]	Pharmacologic actions of 4-aminoquinoline compounds
000037 (1982)	R. O. Day ; P. Sambrook ; G. D. Champion ; G- G. Graham	Antimalarials in Rheumatic Diseases
000051 (1998)	B. Lauren Charous ; Elkan F. Halpern ; Gary C. Steven	Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma
000059 (1995)	Mark J. Borigini ; Harold E. Paulus	Combination therapy
000070 (2000)	Andrew L. Gilman [États-Unis] ; Ka-Wah Chan [États-Unis] ; Mark Mogul [États-Unis] ; Christopher Morris [États-Unis] ; Frederick D. Goldman [États-Unis] ; Michael Boyer [États-Unis] ; Emanuel Cirenza [États-Unis] ; Amitabha Mazumder [États-Unis] ; Edmund Gehan [États-Unis] ; Richard Cahill [États-Unis] ; Stanley Frankel [États-Unis] ; Kirk Schultz [États-Unis]	Hydroxychloroquine for the treatment of chronic graft-versus-host disease
000091 (2004)	S. Bernatsky ; C. A. Pinaeu ; M. Gans ; A. Clarke [Canada]	Adherence to guidelines for the monitoring of antimalarial-related retinal toxicity
000125 (1997)	O. Elkayam [États-Unis] ; M. Yaron [États-Unis] ; G. Zhukovsky [États-Unis] ; R. Segal [États-Unis] ; D. Caspi [États-Unis]	Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients
000149 (1989)	H. N. C. Ihenacho [Nigeria] ; E. Magulike [Nigeria]	CHLOROQUINE ABUSE AND HEART BLOCK IN AFRICANS
000165 (2003)	Xiaohong Zhang [Royaume-Uni] ; Greta J. Sawyer [Royaume-Uni] ; Xuebin Dong [Royaume-Uni] ; Ying Qiu [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni]	The in vivo use of chloroquine to promote non‐viral gene delivery to the liver via the portal vein and bile duct
000208 (2012)	Ljubica Harhaji-Trajkovic [Serbie] ; Katarina Arsikin [Serbie] ; Tamara Kravic-Stevovic [Serbie] ; Sasa Petricevic [Serbie] ; Gordana Tovilovic [Serbie] ; Aleksandar Pantovic [Serbie] ; Nevena Zogovic [Serbie] ; Biljana Ristic [Serbie] ; Kristina Janjetovic [Serbie] ; Vladimir Bumbasirevic [Serbie] ; Vladimir Trajkovic [Serbie]	Chloroquine-Mediated Lysosomal Dysfunction Enhances the Anticancer Effect of Nutrient Deprivation
000214 (2004)	Makoto Tanaka [Japon] ; Chiho Ono [Japon] ; Masayoshi Yamada [Japon]	Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo
000218 (1994)	N. J. L. Gittoes [Royaume-Uni]	Therapeutic progress I: Current treatment of rheumatoid arthritis
000272 (1990)	David A. Joyce	d-Penicillamine
000278 (2000)	Michael H. Schiff [États-Unis] ; Andrew Whelton [États-Unis]	Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis
000295 (2002)	K. Pavelka [République tchèque] ; Š. Forejtová [République tchèque] ; A. Pavelková [République tchèque] ; J. Zvárová [République tchèque] ; J. Rovensk [République tchèque] ; A. Tuchy Ová [République tchèque]	Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
000352 (2011)	Tobias Lahmer [Allemagne] ; Andreas Knopf [Allemagne] ; Ines Lanzl [Allemagne] ; Uwe Heemann [Allemagne] ; Klaus Thuermel [Allemagne]	Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "toxicity" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "toxicity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    toxicity
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021